Tag: biosimilar vs generic

Manufacturing Challenges for Biosimilars: Complex Production and Why It’s Not Like Generic Drugs

Manufacturing Challenges for Biosimilars: Complex Production and Why It’s Not Like Generic Drugs

Biosimilars aren't simple copies like generics-they're complex biologics made in living cells. This article breaks down the real manufacturing challenges: glycosylation, scale-up, cold chain risks, regulatory hurdles, and how new tech is helping manufacturers keep up.